We are live on ! Find out more
GYRE icon

Gyre Therapeutics

34 hedge funds and large institutions have $2.63M invested in Gyre Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

3% less funds holding

Funds holding: 35 → 34 (-1)

8.71% less ownership

Funds ownership: 24.57% → 15.86% (-8.7%)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

84% less capital inflows, than outflows

Capital inflows: $274K | Capital outflows: $1.75M

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
12
Closed
7
Calls
$173​K
Puts
–
Net Calls
+$173​K
Net Calls Change
-⁠$1.12​M

GYRE Hedge Fund Activity: Q4 2022 in Review

34 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q4 2022, worth a combined $2.63M — down 32% from $3.9M a quarter earlier.

Fund positioning in GYRE was balanced in Q4 2022: 7 funds opened new positions, 7 closed out, 8 added to existing stakes and 12 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $136K. The largest seller was Nantahala Capital Management, cutting an estimated $1.15M.

  • 34 institutional investors held Gyre Therapeutics (GYRE) as of Q4 2022, down from 35 in Q3 2022.
  • Funds reported $2.63M of Gyre Therapeutics stock for Q4 2022, down 32% quarter-over-quarter.
  • 7 funds opened new Gyre Therapeutics positions in Q4 2022 and 7 closed out, a net change of 0 holders.
  • The largest Gyre Therapeutics buyer in Q4 2022 was Citadel Advisors, an estimated $136K added.
  • The largest Gyre Therapeutics seller in Q4 2022 was Nantahala Capital Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q4 2022.